Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-28 @ 11:47 PM
Study NCT ID:
NCT00515632
Status:
COMPLETED
Last Update Posted:
2010-07-23
First Post:
2007-08-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Treatment With Balaglitazone in Type 2 Diabetes Patients on Stable Insulin Therapy
Sponsor:
Rheoscience A/S
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
DRF2593-307
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Bente Juel Riis, MD
Old Organization:
Rheoscience A/S